Short answer · Medically reviewed summary · Last updated: 2026-04-07
Morquio Syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is a rare, progressive, inherited metabolic disorder that prevents the body from breaking down long chains of sugar molecules called glycosaminoglycans (GAGs), leading to their accumulation in cells and tissues throughout the body. How the Body is Affected Because the body cannot properly break down these sugar molecules, they build up in the skeletal system, joints, and organs. Morquio Syndrome primarily impacts the skeletal structure, often resulting in short stature, skeletal dysplasia (abnormal bone development), joint laxity, and curvature of the spine.
What is Morquio Syndrome
What is Morquio Syndrome? Plain-language, medically reviewed definition plus the lived reality told by patients.
Morquio Syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is a rare, progressive, inherited metabolic disorder that prevents the body from breaking down long chains of sugar molecules called glycosaminoglycans (GAGs), leading to their accumulation in cells and tissues throughout the body.
How the Body is Affected
Because the body cannot properly break down these sugar molecules, they build up in the skeletal system, joints, and organs. Morquio Syndrome primarily impacts the skeletal structure, often resulting in short stature, skeletal dysplasia (abnormal bone development), joint laxity, and curvature of the spine. In addition to bone health, patients may experience respiratory issues, hearing loss, and vision problems due to corneal clouding. The heart valves and the nervous system can also be affected as the accumulation of GAGs continues over time.
Subtypes and Prevalence
There are two main classifications of Morquio Syndrome: MPS IVA and MPS IVB. These are distinguished by which specific enzyme is deficient. MPS IVA is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfate sulfatase, while MPS IVB is caused by a deficiency in beta-galactosidase. Estimates for the prevalence of Morquio Syndrome vary widely by region, but it is generally estimated to affect between 1 in 200,000 and 1 in 300,000 live births worldwide. It affects males and females equally and is found across all ethnic groups.
Mechanism and Differentiation
Morquio Syndrome is an autosomal recessive disorder, meaning an affected individual must inherit one defective gene copy from each parent. Unlike other forms of mucopolysaccharidosis, Morquio Syndrome is characterized by a lack of significant intellectual disability, which helps clinicians differentiate it from other lysosomal storage disorders. Symptoms typically appear in early childhood, often becoming more noticeable as the child begins to walk and skeletal changes become apparent.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Online Mendelian Inheritance in Man (OMIM)
- National MPS Society
